Combivir (zidovudine/lamivudine or AZT/3TC) is a nucleoside reverse transcriptase inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults and adolescents weighing 30 kg or more. It is listed in the DHHS HIV treatment guidelines as part of an alternative regimen for people starting HIV treatment for the first time, when taken in combination with Edurant, Isentress, Kaletra, Lexiva/Norvir, Prezista/Norvir, Reyataz/Norvir or Sustiva.
Adult single dose: Take one tablet twice daily. Each tablet contains 300 mg of zidovudine and 150 mg of lamivudine.